License and Technology Transfer AgreementLicense and Technology Transfer Agreement • November 5th, 2018 • PTC Therapeutics, Inc. • Pharmaceutical preparations
Type of Contract License and Technology Transfer Agreement (Research and development results belong solely to NTU) Contract No. □□□□□□□□□ Licensed Technology □□□□□□□□□□□□□□□□□
COLLABORATION AND LICENSE AGREEMENT By and between PTC THERAPEUTICS INTERNATIONAL LIMITED ANDCollaboration and License Agreement • November 5th, 2018 • PTC Therapeutics, Inc. • Pharmaceutical preparations • New York
This COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is entered into and made effective as of August 1, 2018 (the “Effective Date”), by and between PTC THERAPEUTICS INTERNATIONAL LIMITED, an Irish corporation, having its principal place of business at 5th Floor, 3 Grand Plaza, Grand Canal Street Upper, Dublin 4, Ireland D04 EE70 (“PTC”), and AKCEA THERAPEUTICS, INC., a Delaware corporation, having its principal place of business at 55 Cambridge Parkway, Suite 100, Cambridge, MA 02142 (“Akcea”). PTC and Akcea shall be referred to herein individually as a “Party” and collectively as the “Parties”.
Collaborative Research AgreementCollaborative Research Agreement • November 5th, 2018 • PTC Therapeutics, Inc. • Pharmaceutical preparations
This Collaborative Research Agreement (“Agreement”) is made and entered into this 30th day of September, 2015 (the “Commencement Date”) by and between National Taiwan University at No. 1, Sec. 4, Roosevelt Road, Taipei, 10617 Taiwan (R.O.C) (hereinafter “NTU”) and Agilis Biotherapeutics, LLC, a Delaware limited liability company duly organized under law and having an address at 245 First St, Suite 1800, Cambridge, MA, 02142 USA (hereinafter “COMPANY”). The Parties do hereby mutually agree the terms and conditions set forth below.
